ArticleScientific reports2016

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.

Len Verbeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.